Browse the evidence

Nutrients involved in one-carbon metabolism (folate, B12, B6, choline, betaine) regulate DNA methylation by modulating the levels of the methyl donor S-adenosylmethionine (SAM) and the inhibitor S-adenosylhomocysteine (SAH).

Ensure adequate intake of B-vitamins, folate, choline, and methionine through diet to support healthy one-carbon metabolism. Do not assume that high-dose supplementation will automatically correct epigenetic markers, as tissue-specific responses vary and excess may not yield benefits.

Bioactive food components such as genistein, EGCG, sulforaphane, and curcumin can modify DNA methylation and histone acetylation, potentially acting as chemopreventive agents by reactivating silenced tumor suppressor genes.

Include foods rich in bioactive compounds (green tea, cruciferous vegetables, turmeric, soy) in your diet. While they may support healthy gene expression patterns, they are not substitutes for medical care or proven cancer treatments, and their potency is lower than pharmaceutical agents.

Inhibition of the host enzyme indoleamine 2,3-dioxygenase 1 (IDO1) improves metabolic health by shifting tryptophan metabolism toward gut microbiota-derived indole metabolites, which restore intestinal barrier integrity and reduce systemic inflammation.

To support metabolic health, prioritize dietary patterns that foster a diverse gut microbiome capable of converting dietary tryptophan into protective indole metabolites. This involves consuming sufficient fiber and diverse plant sources. Emerging research suggests that inhibiting the host enzyme IDO1 (which is upregulated in obesity) allows the microbiota to produce more of these beneficial indoles, thereby improving insulin sensitivity and reducing inflammation. While direct IDO1 inhibitors are not yet standard care, supporting the microbiome's ability to perform this conversion is a key mechanistic target.

Dietary tryptophan metabolism via the kynurenine pathway (specifically IDO1 activity) is shifted toward protective indole metabolites when gut barrier integrity is maintained, whereas high-fat diets and inflammation shift it toward kynurenine, promoting inflammation and metabolic disease.

Your body processes dietary tryptophan differently depending on your metabolic health. In a healthy state, gut bacteria convert it into protective indoles that support the gut barrier. In states of obesity or high-fat diet consumption, the body's own enzymes (IDO1) take over, producing inflammatory byproducts. Maintaining gut health through diet helps preserve the beneficial bacterial pathway.

The availability of healthy food items (fruits, vegetables, overall quality) within consumer food stores is not consistently associated with lower BMI or improved dietary patterns, and proximity to healthy stores does not necessarily lead to better health outcomes.

Don't assume that stocking healthy food in a store will automatically improve community health. Research shows that simply having healthy options available does not necessarily lead to lower BMI or better diets. To make a difference, interventions must also address price, marketing, and purchasing habits, not just availability.

Stores in low-income or high-minority neighborhoods often have less availability of healthy food and higher prices for healthy items compared to stores in higher-income neighborhoods, although these findings are inconsistent across studies.

Be aware that food environments are not equal. Low-income and minority neighborhoods often have less healthy food available and higher prices for healthy items. Addressing these disparities requires targeted interventions, not just general availability improvements.

Concurrent chemoradiation (CCR) in head and neck cancer patients induces rapid lean body mass (LBM) loss and physical functional decline, driven by an inflammatory state rather than caloric deficit.

For patients undergoing head and neck cancer treatment, standard high-calorie nutritional supplements may not prevent muscle loss because the treatment triggers an inflammatory metabolic shift. Focus on preserving muscle through targeted anti-inflammatory strategies and physical activity support, rather than just increasing caloric intake, as the body is actively catabolizing lean tissue despite adequate food consumption.

Elevated inflammatory cytokines (IL-6, IL-1b, IL-10) are strongly associated with functional decline and loss of physical activity levels in head and neck cancer patients undergoing chemoradiation.

Monitor inflammatory markers if possible, as they correlate with functional loss. Standard nutritional advice should be combined with anti-inflammatory strategies and exercise to support lean tissue, as inflammation directly drives the loss of physical independence.

Skeletal muscle sarcolipin (SLN)-mediated uncoupling of the SERCA pump increases energy expenditure and prevents diet-induced obesity.

This research suggests that increasing the activity of the Sarcolipin (SLN) protein in your skeletal muscles could help your body burn more calories passively, even at rest. While you cannot currently take a 'SLN pill', this mechanism highlights why maintaining muscle mass (especially slow-twitch fibers) is crucial for metabolic health and weight management. Future therapies may target this pathway to treat obesity without requiring intense physical activity.

Acute resistance training increases plasma Interleukin-6 (IL-6) levels, which acts as an anti-inflammatory myokine when derived from muscle, promoting fat oxidation via AMPK activation and inhibiting pro-inflammatory cytokines like TNF-α.

Do not fear the rise in IL-6 after a resistance workout. When your muscles produce IL-6 during exercise, it acts as a beneficial signal that helps burn fat and improves insulin sensitivity, unlike the chronic IL-6 produced by fat tissue which contributes to inflammation.

Elevated serum levels of the pro-inflammatory cytokine IL-6 and the IL-6/IL-10 ratio are positively associated with the presence of sarcopenia in elderly individuals.

For older adults, high levels of systemic inflammation (specifically IL-6) are linked to muscle loss. While you cannot directly 'dose' IL-6, managing chronic inflammation through diet, exercise, and medical management of inflammatory conditions may help preserve muscle mass. The study highlights that inflammation is a key biological driver, not just a side effect.

Elevated levels of the anti-inflammatory cytokine IL-10 are also positively associated with sarcopenia in the elderly, potentially acting as a compensatory response to chronic inflammation.

High IL-10 levels in sarcopenia may indicate the body's attempt to fight inflammation. This suggests that simply boosting anti-inflammatory markers might not be enough if the underlying pro-inflammatory drive (IL-6) is too strong. Focus on reducing overall inflammatory load.

Dietary flavonoids reduce intestinal inflammation and improve barrier integrity in obesity-associated models by suppressing the TLR4/NF-κB signaling pathway and down-regulating pro-inflammatory enzymes like COX-2 and iNOS.

To leverage flavonoids for gut health and inflammation, prioritize foods rich in specific flavonoids (like citrus for naringenin, tea for catechins, or red wine for anthocyanidins) because they interact directly with gut bacteria and intestinal cells. The benefit comes from local gut effects and microbiota modulation rather than high systemic blood levels.

Administration of the highly proliferative probiotic strain Bifidobacterium animalis ssp. lactis GCL2505 (BlaG) ameliorates metabolic disorders, specifically improving glucose tolerance and reducing visceral fat accumulation, by modulating gut microbiota to elevate acetate levels and subsequently increasing glucagon-like peptide-1 (GLP-1) secretion.

If you are looking to use probiotics to support metabolic health, specifically glucose control and fat management, the specific strain matters significantly. This research suggests that Bifidobacterium animalis ssp. lactis GCL2505, taken daily at 1 billion CFU, may help improve glucose tolerance and reduce visceral fat in the context of a high-fat diet by increasing gut acetate and GLP-1. However, this was observed in mice, and human results may vary. It highlights that 'proliferative' strains might be more effective than non-proliferative ones for these specific outcomes.

Obesity induces systemic DNA damage and inhibits DNA repair mechanisms through chronic inflammation and oxidative stress, thereby increasing the risk of metabolic disorders and cancer.

Maintaining a healthy weight is critical for protecting your DNA from damage caused by inflammation and oxidative stress. This damage accumulates over time and increases the risk of serious conditions like cancer and diabetes. However, the damage is not permanent; losing weight and improving diet quality can reverse this process and restore genomic stability.

Small molecule sirtuin activators, specifically polyphenols like resveratrol, extend lifespan in yeast by mimicking the effects of calorie restriction through the activation of Sir2.

While direct human lifespan extension is not yet proven, consuming plant-based polyphenols (like resveratrol found in grapes) may activate longevity pathways (sirtuins) that mimic the benefits of calorie restriction. This suggests that a diet rich in stressed plants (grapes, peanuts, medicinal herbs) could support cellular health and stress resistance.

Probiotic administration in early life, likely via the production of short-chain fatty acids (SCFAs) like butyrate, can restore gut microbiota balance and exert epigenetic effects (HDAC inhibition) that prevent chronic immune-mediated diseases.

If considering probiotics for an infant (especially after C-section or antibiotic use), consult a pediatrician. The goal is to support a healthy gut microbiota early in life, which may help program a robust immune system and reduce the risk of allergies via epigenetic mechanisms like butyrate production.

Steering the nutrition transition toward positive health outcomes requires holistic, integrated public health policies that simultaneously address under- and over-nutrition through community involvement and stakeholder engagement.

Public health officials should design integrated programs that improve food security and micronutrient intake while preventing excessive calorie consumption. This involves engaging communities, regulating food marketing, and ensuring healthy options are affordable and available.

IL-22, produced by Th22 cells, has a beneficial effect on NAFLD by alleviating steatosis and reducing transaminase levels through STAT3-mediated mechanisms, although its role in obesity pathogenesis is complex and context-dependent.

IL-22 shows promise in reducing liver fat and inflammation in NAFLD models. While not a current standalone therapy, understanding its protective role highlights the potential of targeting specific cytokine pathways for liver health. Current management focuses on weight loss and metabolic control.

Obesity is associated with an increased risk of differentiated thyroid cancer (DTC), potentially mediated by higher TSH levels, insulin/IGF-1 pathways, and adipokines like leptin.

Obesity is linked to a higher risk of thyroid cancer. This may be due to higher TSH, insulin, and fat-derived hormones. Maintaining a healthy weight may help reduce this risk.

Dietary taurine supplementation prevents high-fat diet-induced obesity in mice by increasing resting energy expenditure and upregulating fatty acid oxidation genes in white adipose tissue, without altering food intake or physical activity.

This research suggests that taurine may help prevent obesity by boosting your resting metabolism, specifically by helping your fat cells burn more fat. In mice, a very high dose of taurine prevented weight gain on a high-fat diet without changing how much they ate or moved. For humans, this implies that ensuring adequate taurine intake (found in seafood) might support metabolic health, although the effective dose in mice was extremely high compared to typical human supplementation. It is not a substitute for a balanced diet, but may be a supportive factor for metabolic efficiency.

Increased availability and convenience of calorie-dense foods (e.g., fast food, processed meals, large portions) contributes to population obesity by increasing per capita energy intake relative to expenditure.

To combat obesity, focus on reducing the availability and convenience of calorie-dense foods in your environment, such as limiting access to fast food and large portions, rather than relying solely on willpower.

Caloric restriction extends lifespan and promotes longevity by inducing dramatic changes in mitochondrial protein acetylation, thereby enhancing mitochondrial adaptation to reduced caloric intake.

Caloric restriction is a proven method to extend lifespan in various species by altering how mitochondria function. This happens through changes in protein acetylation, which helps cells adapt to lower energy availability. While strict restriction is hard to maintain, the underlying mechanism suggests that managing energy intake to avoid overfeeding may support healthy aging processes.

Financial incentives in behavioral obesity treatments do not produce a statistically significant effect on weight loss or maintenance at 12 and 18 months compared to treatments without incentives.

Relying on financial rewards to lose weight is not supported by evidence for long-term success. While some studies showed weak trends for higher incentive amounts or behavior-based rewards, the overall effect on weight loss is negligible. Focus on sustainable behavioral strategies rather than monetary incentives.